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produced for each patient. All plans had a mean CTV dose of 
18.75 Gy per fraction (=100% dose) and 95% minimum CTV 
dose coverage. The PTV was covered by 50%, 67%_S, 67% (our 
standard), 80%, and 95% of the prescribed dose, respectively. 
The 67%_S plan was an alternative to the standard 67% plan 
made with maximum conformity, i.e. as steep as possible 
dose gradient from 95% to 67% outside the CTV. The 50%, 
67%_S, 80%, and 95% plans were renormalized to be isotoxic 
with the standard 67% plan, i.e. to give the same risk of 
radiation induced liver disease (RILD) according to the NTCP-
model of Dawson et al. (Acta Oncol., 2006). For each patient 
and plan, the dosimetric effects of the observed intrafraction 
motion were investigated by calculating the delivered dose 
by an in-house developed method for motion-including dose 
reconstruction. 
 
Results: The figure shows the CTV mean dose and D99 for 
each plan type and each patient as planned (start of each 
arrow) and as delivered with the known tumor motion (end of 
each arrow). The mean values over all patients are presented 
in Table 1. The planned CTV dose decreased markedly from 
63.3Gy to 47.0Gy (average mean dose) and from 60.5Gy to 
44.9Gy (average D99) as the prescription level to the PTV rim 
was increased from 50% to 95%. Although intrafraction motion 
reduced this CTV dose difference the CTV dose of plans with 
high PTV prescription levels remained inferior to isotoxic 
plans with low PTV prescription levels even when motion was 
included in the dose calculations, see Table 1. The absolute 
dose delivered to the liver was almost unaffected by 
intrafraction motion as seen in Table 1. 
 
 
Conclusion: The dose level at the PTV rim has a large effect 
on the risk of RILD. Using a low dose at the PTV rim, where 
the probability of CTV presence during treatment was low, 
allowed for higher CTV dose for iso-toxic conditions in 50% 
and 67%_S plans. Although these plans were less robust to 
intra-fraction motion, their CTV dose remained superior to 
the 80% and 95% plans when motion effects were included. 
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Purpose or Objective: To describe the commissioning 
process and initial experience using real-anatomy, real-time 
tracking and gating with MRI-guided radiation therapy. 
 
Material and Methods: An MR-IGRT system was commissioned 
to enable real-time anatomy tracking and gating. The 
imaging rate is 4 frames per second; the radiation shuts off 
when the anatomy of interest is automatically detected 
outside a pre-defined treatment region. The specific 
commissioning tests were driven by the goal of compensating 
for the inherent system latency such that there would not be 
an increase in treatment margins (i.e., GTV to PTV 
expansion). Dosimetric and geometric accuracy was 
evaluated by using both a commercial and an in-house motion 
phantoms with film and ionization chamber dosimetry. 
Clinical procedures were developed to maintain the 
established accuracy during actual patient treatments. 
 
Results: Since initial clinical implementation, 51 patients 
have been treated using the gating and tracking capability of 
the MR-IGRT system (out of a total of 193). Based on system 
characteristics established during commissioning tests, the 
standard-of-care GTV to PTV expansion was maintained (e.g., 
5 mm for abdominal tumors). Dosimetric accuracy was 
established via ionization chamber measurements that 
showed a 1.28%±1.7% average difference when comparing 
gated (with motion) vs. non-gated (without motion) delivery 
for typical IMRT and open field plans. Spatial accuracy was 
established via film dosimetric measurements and spatial 
integrity measurements to be on the order of 2 mm. This 
level of accuracy is maintained during patient delivery by 
using the following procedure: setting up to an exhale 
breath-hold position and using a gating boundary around the 
region of interest that's 2 mm less than the PTV of interest 
(e.g., 3 mm expansion of the GTV if a 5-mm expansion to 
PTV). Depending on the location of the tumor (or other 
anatomy of interest), duty cycles so far have ranged from 
about 50% (especially for tumors close to diaphragm) to 
about 80% (for pancreatic lesions and other abdominal sites 
excluding liver). Examples are shown in figure below. 
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Conclusion: We have clinically demonstrated the practicality 
of real-time, real-anatomy tracking and have shown that 
clinical parameters can be selected which allow efficient 
treatment delivery. This work will be used as a foundation 
for evaluating options for treatment volume reduction.  
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Purpose or Objective: In current radiotherapy for hilar or 
mediastinal lymph node metastases large treatment margins 
are used. Online MRI guidance will offer direct visualization 
of the lymph nodes, allowing highly conformal treatments 
using gating or tracking techniques. However, both 
respiratory and cardiac induced motion are expected to 
cause significant displacements. In this study we have 
assessed the relative contributions of the heart and 
respiration to the motion of hilar lymph nodes in order to 
find the optimal motion compensation strategy on the MR-
Linac. 
 
Material and Methods: Five healthy subjects were imaged 
during free-breathing using cine-MRI on a 1.5T MRI scanner. 
Sagittal and coronal scans, positioned through the center of 
the hilar lymph nodes, were acquired interleaved using a 
balanced Steady-State Free-Precession (bSSFP) sequence, 
providing T2/T1 contrast; Tacq = 1:08 min, TE/TR = 
1.92/0.96 ms, 1.38 x 1.38 mm2, 7 mm slices, at a rate of 4 
frames/sec. The motion in the region of the hilar lymph 
nodes was estimated using an optical flow algorithm [1]. As 
the cardiac induced motion manifests as a modulation of the 
respiratory motion waveform, power spectra were calculated 
to assess the relative contribution of each source of motion. 
The respiratory-to-cardiac power ratios were determined 
from the power spectrum by dividing the respiratory peak by 
the cardiac peak. 
 
Results: Typical results of optical flow analysis on sagittal 
and coronal slices in Figs. 1A-B. Cardiac motion is shown to 
have significant contributions in left-right (LR) and anterior-
posterior (AP) directions as shown by the power spectra (Fig. 
1C). The mean lymph node displacements and respiratory-to-
cardiac power ratios are listed in Table 1. The mean 
displacement was largest in CC direction. The respiratory-to-
cardiac power ratio was largest in CC direction, while in LR 
direction the lowest values are observed. This implies that 
cardiac induced motion contributes most in LR direction, 
whereas respiratory induced motion dominates most in CC 
direction. 
 
Conclusion: These preliminary results in five volunteers 
showed that cardiac motion has a significant contribution on 
the motion of hilar structures. This indicates that the cardiac 
component cannot be ignored when implementing motion 
compensation strategies. Soon, this study will start with the 
inclusion of lung cancer patients with lymph nodes 
metastases. The power spectra will be used to separate the 
cardiac from the respiratory signal to determine the exact 
cardiac induced displacement. 
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Purpose or Objective: Couch and MLC tracking are promising 
methods for real-time motion compensation for moving 
targets during radiation therapy. Couch and MLC tracking 
experiments have mainly been performed by different 
research groups, and no direct comparison of couch and MLC 
tracking of VMAT plans has been published. Varian TrueBeam 
2.0 includes a prototype tracking system with selectable 
couch or MLC compensation. This study provides a direct 
comparison of the two tracking types with an otherwise 
identical setup. 
 
Material and Methods: Several experiments were performed 
to characterize the geometric and dosimetric performance of 
electromagnetic guided couch and MLC tracking on a 
TrueBeam linear accelerator. The tracking system latency 
was determined without motion prediction as the time lag 
between sinusoidal target motion and the compensating 
motion of the couch or MLC as recorded by continuous MV 
portal imaging. The geometric and dosimetric tracking 
accuracy was measured in tracking experiments with motion 
phantoms that reproduced four prostate and four lung tumor 
trajectories. A Kalman filter was used for prediction in these 
experiments. The geometric tracking error in beam’s eye 
view was determined as the distance between an embedded 
gold marker embedded and the circular MLC aperture in 
continuous MV images. The dosimetric tracking error was 
quantified as the Delta4-measured 2%/2mm gamma failure 
rate of a low and a high modulation VMAT plan delivered with 
the eight motion trajectories and using the static dose 
distribution as reference. 
